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Introduction
Alphaviruses are enveloped (+)-strand RNA
viruses of the togavirus family that are increas-
ingly being applied as expression vectors. The
most widely used alphaviral vectors are based
on Semliki Forest virus (SFV), Sindbis virus
(SIN), and Venezuelan equine encephalitis
virus (VEE), which infect cells via the major
histocompatibility class I molecule, laminin,
and other receptors (1). The original SFV iso-
late (strain L10) was obtained from mosquitoes
from the Semliki Forest, Uganda, in 1944 (2),
while the original SIN isolate (strain AR339)
stems from mosquitoes collected near Sindbis,
Egypt, in 1952 (3); VEE was originally isolated
from the brain of horses in the Guajira region
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Abstract
Alphaviruses are small, enveloped positive-strand RNA viruses that have been successfully
transformed into expression vectors in the case of Semliki Forest virus (SFV), Sindbis virus (SIN),
and Venezuelan equine encephalitis virus. Compared to other viral vectors, their advantages are
easy and fast generation of recombinant viral particles, rapid onset, and high-level transgene
expression. When applied to neuronal tissue, SFV and SIN vectors possess the additional advan-
tage of efﬁciently and preferentially transducing neurons rather than non-neuronal cells. This arti-
cle gives an overview of the biology of SFV and SIN, their generation into expression vectors, and
their application in neurobiology, with particular emphasis on the transduction of hippocampal
neurons. In addition, it describes the more recent development of alphaviral vectors with
decreased or absent cytotoxicity and lowered transgene expression, temperature-controllable gene
expression, and altered host-cell speciﬁcity in the central nervous system (CNS). Finally, the
review evaluates the use of SFV and SIN vectors in hippocampal tissue cultures vs recombinant
lentivirus, adenovirus type 5, adeno-associated virus type 2, and measles virus.
Index Entries: Semliki Forest virus; Sindbis virus; RNA virus; expression vector; green ﬂuores-
cent protein; hippocampus.
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of Venezuela (4). Since their initial identiﬁca-
tion, SFV and SIN have become the model
alphaviruses, providing detailed knowledge of
their molecular biology and replication in host
cells. While initial viral vectors were based on
DNA viruses (such as vaccinia virus, aden-
ovirus, and adeno-associated virus), the molec-
ular cloning of SFV and SIN as cDNAs has
enabled the subsequent development of these
RNA viruses into efﬁcient, high-level expres-
sion systems.
In nature, alphaviruses cycle predominantly
between mosquitoes and small mammals and
birds. Wild-type SFV and SIN target neurons
in the CNS, induce neuronal apoptosis, and
cause encephalitis in rodents, sometimes with
lethal outcome (5). Data from studies in mice
and rats with replication-competent SFV and
SIN indicate that neurotropism and neuronal
survival are determined by both the viral
strain and the age of the injected animals.
While all strains cause fatal disease in newborn
and suckling rodents, several strains (includ-
ing SFV A7, its derivative SFV A7 [74] and SIN
[AR339]) are avirulent for adult animals and
cause limited CNS infection, which is cleared
within 7–10 ds post-infection (6–9).
Alphaviral Replication
The ﬁrst two thirds of the 11.8 kb long,
capped RNA genome serve as mRNA for the
polyprotein containing nonstructural proteins
1–4 (nsP1–4), which is post-translationally
processed into the four proteins that are
required for transcription and replication of
the alphaviral RNA. NsP1 has methyl- and
guanyltransferase activity; nsP2 is involved in
the proteolytic processing of nsP1–4 and regu-
lates viral RNA synthesis; and nsP4 is the viral
RNA polymerase (1). NsP3 is a phosphoprotein
(10) involved in alphaviral RNA replication
(11), but its precise function remains unknown.
Within the ﬁrst hours of infection, the nsP123
polyprotein and nsP4 generate the negative-
strand RNA that is complementary to the viral
genome. Once the nsP123 polyprotein has been
cleaved (through nsP2), the negative-strand
RNA serves as a template for efﬁcient synthe-
sis of both new positive-strand genomic RNA,
and subgenomic 26S RNA that encodes the
viral structural proteins. The subgenomic RNA
is translated into the polyprotein that is then
processed into the capsid and spike proteins,
p62 and E1. Owing to an encapsulation signal
in the nsP1 gene for SIN and nsP2 gene for SFV,
capsid proteins assemble with genomic RNA
molecules to form nucleocapsids, which then
bud from the cell membrane where processed
spike proteins have been inserted (1). Figure 1
gives a schematic overview of the alphaviral
replication and virus assembly.
Alphaviral Vectors: The 
Replicon System
Vectors for SFV and SIN as well as the
closely related VEE have been developed to
express high levels of foreign genes in vitro
and in vivo (12–15). Owing to their promiscu-
ous usage of cell surface receptors for attach-
ment, an extremely wide range of host cells,
including most cell lines and many primary
cultures from insect to mammalian cells, can be
infected and successfully transduced (16,17).
While fully replication-proﬁcient alphaviral
vectors have been used (18), a more common
approach is the replicon system (see Fig. 2) in
which the transgene in the “vector RNA”
replaces the viral structural protein genes
(13–15). Vector RNAs are self-replicating and
are referred to as “replicons.” They must be co-
transfected with defective “helper RNA” to be
packaged into infectious particles. Both vector
and helper RNAs are obtained by in vitro tran-
scription from plasmids containing their
respective cDNAs. A vector RNA-encoding
plasmid of the SFV system, pSFV2gen (19), is
shown in Figure 3. It is based on pSFV1 (13)
but contains a multiple-cloning site with addi-
tional unique restriction sites.
Defective helper RNAs have a large deletion
in nsP1–4 and are not self-replicating, but can
be replicated and transcribed by the nsPs pro-
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vided by the replicons. Helper subgenomic
RNAs are translated to provide the capsid and
spike proteins for replicon assembly under
conditions in which helper RNAs are not pack-
aged. Alternatively, the capsid and spike pro-
teins can be supplied from stably transfected
cells line (20). Packaged replicons derived by
this approach have been termed “suicide vec-
tors” (21) because they infect target cells with-
out the capability of forming new infectious
particles (as the introduced replicon genome is
lacking the structural protein genes).
A fully DNA-based SFV expression system
employs vector and helper plasmids with the
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Fig. 1. Alphaviral replication and assembly. Upon attachment of the viral particle to the cell and entry via
endocytosis, the viral nucleocapsid is released into the cytoplasm. Binding of the nucleocapsid to ribosomes
then triggers the uncoating process that releases the genomic (+)-strand RNA into the cytoplasm. The genomic
RNA is then translated into the nsP1–4 preprotein that synthesizes the complementary (–)-strand genome. When
nsP1–4 is cleaved into the separate proteins, many copies of both (+)-strand genomic and subgenomic RNA are
formed. The subgenomic RNA is translated into the capsid protein (C) and the envelope proteins (p62, the pre-
cursor of the E2 and E3 spike proteins; the 6K protein; and E1). Owing to the packaging signal in the nsP region
of the genome, the genomic RNA is bound to capsid proteins, thereby forming the nucleocapsid. Interaction of
the nucleocapsid with envelope glycoproteins (spikes), which have penetrated into the host cell membrane, lib-
erates the virus particle from the host cell. (Modiﬁcation of the ﬁgure kindly provided by Dr. Sondra Schlesinger,
Washington University School of Medicine, St. Louis, USA.)
prokaryotic SP6 RNA polymerase promoter
(for in vitro transcription) replaced by an RNA
polymerase II-dependent promoter, permitting
expression in eukaryotic cells (22). The viral
titers obtained by co-transfection of these plas-
mids into baby hamster kidney 21 (BHK) and
COS-1 cells, however, are signiﬁcantly lower
than the titers obtained by co-electroporation
of vector and helper RNAs.
In a different approach, the helper RNA, in
addition to the vector RNA, similarly contains
a packaging signal, resulting in the co-packag-
ing of both vector and helper RNA into infec-
tious particles. Virus particles derived by this
method have been successfully used as an efﬁ-
cient expression cloning system for receptors
and other membrane proteins, as well as for
secreted and intracellular proteins (23).
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Fig. 2. Packaging of SFV and SIN replicons. Vector RNA encoding nonstructural proteins 1–4 (nsP1–4) and
the transgene (shaded) under the control of the 26S subgenomic RNA promoter (hatched), and defective helper
RNA (encoding the structural alphavirus proteins downstream of the subgenomic RNA promoter) are obtained
by in vitro transcription from their respective cDNAs and co-transfected into BHK cells. Only the vector RNA
contains the packaging signal required for encapsidation into the nucleocapsid. Within the cytoplasm, vector
RNA replication occurs through the action of nsP1–4. In parallel, the defective helper RNA is replicated and
transcribed by nsP1–4, and the capsid protein C, 6K protein, glycoprotein E1, and precursor protein p62 (which
is later cleaved into the E2 and E3 spike proteins) are translated. Capsid proteins package only vector RNA,
while spike proteins are incorporated into the cell membrane. Nucleocapsids dock to the cell membrane where
spike proteins have been incorporated, thus allowing the budding of virus particles.
Biosafety
While other alphaviruses such as VEE and
rubella virus are human pathogens, wild-type
SFV and SIN normally cause less severe infec-
tions in humans, with SIN leading to mild fever,
joint-pain, and rash (5). For SFV, human infec-
tion is relatively common, but this has been
linked to disease in only two occasions (5). This
explains why SFV is classiﬁed as biosafety level
3 in the USA, but with the condition that most
activities (including the work with SFV vectors)
can be carried out at level 2, which is also the
biosafety level for SIN (US HHS Publication no.
CDC 93-8395, 1993) (24). In the European Union
and in Switzerland, SFV and SIN are classiﬁed
as biosafety level 2 (EC Council Directive
93/88/EEC, 1993; statement of the Swiss expert
committee for biosafety on the classiﬁcation of
work with genetically modiﬁed viral vectors,
August 2001).
SFV and SIN expression systems using repli-
cons (cf, above) consist of two components: the
expression vector and the helper plasmid.
When the original SFV helper plasmid is used,
fully replication-proﬁcient viral particles may
form by homologous recombination in BHK
cells. In co-transfections of SFV expression vec-
tors with the pSFV-Helper2 plasmid (91), how-
ever, no infectious virus particles can arise due
to point mutations in the structural genes,
which prevent cleavage of the p62 precursor
protein into functional E2 and E3 envelope gly-
coproteins. The resulting SFV particles are non-
infectious until activated with α-chymotrypsin.
Therefore, viral vectors packaged with pSFV-
Helper2 have been grouped into biosafety
level 1 classiﬁcations in several European
countries, including Germany and Switzerland
(http://www.rki.de/GENTEC/ZKBS/ZKBS.
HTM; statement of the Swiss expert committee
for biosafety on the classiﬁcation of work with
genetically modiﬁed viral vectors, August
2001).
Applications in Neurobiology
Transduction of Neurons
Both SFV and SIN vectors have been used
successfully to transduce neurons in primary
and tissue cultures (see Fig. 4) and in vivo (e.g.,
refs. 25–32). Organotypic cultures of hip-
pocampal slices (33,34) represent a highly
applicable preparation that permits rapid tests
for recombinant proteins in a system that is
more similar to the in vivo situation than cul-
tures of dissociated neurons. SFV and SIN vec-
tors deliver genes efﬁciently to neurons in
organotypic hippocampal slices prepared from
neonatal and postnatal rats (see Fig. 4A,B; refs.
27,28,35). In collaboration with my colleague
Kenneth Lundstrom, I successfully established
a standardized protocol for the application of
alphaviral vectors in this test system (36,37).
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Fig. 3. Topological map of the pSFV2gen vector
plasmid. Nucleotides are numbered with the ﬁrst
nucleotide of the cDNA derived from SFV4 genomic
RNA deﬁned as 1. The locations of the nsP1–4 genes
encoding the nonstructural proteins, the ampicillin
resistance gene, the SP6 promoter for in vitro tran-
scription, the alphaviral 26S subgenomic RNA pro-
moter (SG), and the poly-A sequence are indicated.
The graph contains the unique restriction sites of the
multiple cloning site for inserting genes of interest, as
well as the linearization sites (underlined) for in vitro
transcription.
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Fig. 4. Transduction of cultured rat hippocampal slices (A,B) and primary rat hippocampal neurons (C) by
using SFV and SIN vectors. (A) Rat hippocampal slices from P0 and P6 rats were cultured for 1 and 45 d (P0 vs
P6, respectively) and then infected with 100- to 10,000-diluted SFV and SIN encoding enhanced green ﬂuores-
cent protein (GFP) or E. coli β-galactosidase (LacZ). Dark ﬁeld (top left) and ﬂuorescence micrographs of living
slices were taken at 2 d post-infection, whereas bright ﬁeld images were obtained from slices ﬁxed and stained
for LacZ expression at 1 d post-infection. Transduced cells appear in green and blue for GFP and LacZ, respec-
tively. Propidium iodide staining was performed on living slices at 5 d post-infection; an FITC ﬁlter set with a
long-pass emission ﬁlter revealed both infected cells and propidium iodide-positive (red), non-viable cells (bot-
tom middle), whereas a rhodamine ﬁlter set revealed only propidium iodide ﬂuorescence (bottom right). Note
that most infected cells exclude propidium iodide, and therefore, appear to be intact. Abbreviations: DG, den-
tate gyrus; so, stratum oriens; sp, stratum pyramidale; sr, stratum radiatum. Bar: 330 µm (left and middle panels
of top and middle row) and 80 µm (remaining panels). Magniﬁcations are from CA1 regions, except for the bot-
tom left panel which shows infected CA3 pyramidal cells. (B) Confocal image of the CA1 region from a rat hip-
pocampal slice culture at 2 d after infection with an SFV expressing GFP. The color code indicates the depth of
the location of GFP-positive cells within the slice. Note that most GFP-positive cells are pyramidal cells (image
kindly provided by Dr. R. Anne McKinney, University of Zurich, Switzerland). (C) Confocal image of a rat hip-
pocampal neuron in culture, 1 d after infection with an SFV vector expressing GFP. GFP ﬂuorescence is shown
in green, while in vivo labeling of active boutons with an anti-synaptotagmin-I antibody is shown in red (image
kindly provided by Dr. Antonio Malgaroli, Scientiﬁc Institute San Raffaele, Milano, Italy).
Table 1
Advantages and Disadvantages of Conventional SFV and SIN Vectors Compared to Other Viral 
and Non-Viral Transduction Techniques
Advantages Disadvantages
Rapid production Inhibition of host cell protein synthesis and cytotoxicity
Extremely high viral titers obtained (stocks Not applicable for long-term gene transfer
are therefore used at ≤10,000-fold dilution)
Preferential and efﬁcient infection of neurons No choice of promoter
Fast gene expression (within hours)
High transgene expression levels
Note that more recently developed, mutant alphaviral vectors eliminate speciﬁc disadvantages (cf Table 3).
Compared to other viral vectors, biolistic
and lipid-based transfection methods, SFV,
and SIN vectors cause rapid, high-level, and
efficient transduction (>95% in primary neu-
rons, see Fig. 4C). It is also beneficial for many
studies that conventional SFV and SIN vec-
tors preferentially transduce neurons rather
than non-neuronal cells, causing pyramidal
cells and interneurons, in hippocampal slice
cultures, to constitute approx 90% of all cells
positive for green fluorescent protein (GFP;
see Fig. 4B) (27,28).
Aside from their advantages (see Table 1),
wild-type alphaviral vectors (13,15) retain the
disadvantage of inhibiting host cell protein
synthesis, which eventually causes cell death.
While neurotoxic effects appear relatively fast
(within 1–2 d) and are readily observed in cul-
tures of dissociated hippocampal neurons
(25,38,39), they are delayed by several days in
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Table 2
Proteins that Have Been Functionally (Over)expressed with SFV and SIN Vectors in Neurons
Recombinant protein Comments Refs.
Intracellular proteins
β-galactosidase Reporter molecule (27,29,30,62)
GFP Reporter molecule (27,30,32,63)
NEDD-2 Cysteine protease (64)
Aspartylglucosaminidase Enzyme (65)
p16ink4,p21waf/cip,p27kip1 Cyclin-dependent kinase inhibitors (66)
Cdk4, Cdk6 (dominant-negative) G1 cyclin-dependent kinases (66)
CaMKII (truncated) Kinase (67)
Munc13-1, Munc 18-1 Synaptic vesicle priming proteins (68,69)
Snapin Binds synaptic protein SNAP-25 (70)
Syntaphilin SNARE assembly regulator (71)
Homer-1a and 1c Postsynaptic scaffolding protein a
Membrane proteins
GABAA receptor α1 and β2 subunits Ligand-gated ion channel (48,72)
Serotonin 5-HT3 receptor Ligand-gated ion channel (73)
P2X2 receptor Ligand-gated ion channel (74)
Calcium channel β4 subunit Calcium channel regulator (26)
GluR1, GluR2, GluR4 AMPA receptor subunits (31,40,75–77)
GluR2 C-term Blocks Pick1-GluR2/3 interaction (78)
VGLUT1/BNP1, VGLUT2/DNPI Vesicular glutamate transporters (79,80)
Connexin 36 Increases intercellular coupling a
SNAP-25 Synaptic protein (81,82)
SGT Synaptic vesicle surface protein (83)
GFP-tagged pleckstrin homology domain Indicator of intracellular IP3 dynamics (84)
Amyloid precursor protein (APP) Cleaved into β-amyloid peptide (85)
Presenilin-1 Associated with familial AD (86)
Catechol O-methyltransferase Membrane-bound enzyme (87)
Rab8 Membrane-associated GTPase (25)
Neprilysin Membrane-associated metalloendopeptidase (88)
VIP21 Integral membrane protein (25)
polymeric immunoglobulin receptor Binds immunoglobulins A and M (89)
F protein Measles virus glycoprotein a
a Own, unpublished data.
hippocampal slice cultures. Based on propid-
ium iodide exclusion experiments (cf, Fig. 4A,
bottom middle and right panels) and electro-
physiological tests of passive and active
membrane properties (i.e., resting membrane
potential and conductance, action potential
generation, firing accommodation, and
hyperpolarization-induced currents), we
found pyramidal cells in this preparation to
survive for 2–5 d post-infection (27,28). In any
case, as alphaviral GFP expression in tissue
cultures is fast (detectable within 4–6 h) and
transient (peaking at 1 d post-infection) (28),
the time window to examine transgene effects
suffices for many physiological studies,
including the microscopical and electrophysi-
ological analysis of synaptic function (e.g.,
Fig. 4C; ref. 40), and the real-time investiga-
tion of activity-dependent morphological
changes (32).
Table 2 summarizes different transgenes
that have been introduced into hippocampal
and other neurons by using packaged SFV
and SIN replicons. While it lists many intra-
cellular and membrane proteins that could be
expressed in a functional manner, our
attempts to functionally overexpress the tran-
scription factors EGR1 and EGR2 with the less
cytopathic SFV(PD) mutant (38,39) were not
successful. The analysis with an anti-EGR1
antibody revealed the presence of immunore-
active protein in the cytoplasm rather than the
nucleus of infected cells; and functional tests
for transactivation of EGR1-dependent
luciferase reporter gene expression were not
successful (M.J. Fend, K. Lundstrom, and
M.U. Ehrengruber, unpublished data). By
contrast, when inserted into adenoviral vec-
tors, exactly the same EGR1 cDNA was able to
induce EGR1-dependent gene expression (41).
These results indicate that the present alpha-
viral vectors may not be applicable for the
functional study of speciﬁc transcription fac-
tors. Another report with a GFP-tagged tran-
scription factor (ATF-4) overexpressed by SFV
did not examine whether ATF-4 transactivat-
ing function was retained in infected cells (42).
Heterologous Expression 
of Neuronal Proteins
Owing to the intracellular ampliﬁcation
processes inherent in alphaviral genome repli-
cation, SFV and SIN vectors generate
extremely high transgene expression levels in
infected cells. These levels can be problematic
in cases where the transgene product has cyto-
toxic effects (as in the human neurokinin-1
receptor [43]) or because it does not match
physiological levels. On the other hand,
alphaviral vectors are particularly advanta-
geous when applied in cell lines for generating
high amounts of recombinant protein required
(e.g., for the drug screening of receptors and
the puriﬁcation of proteins for structural stud-
ies and crystallization. Compared to the bac-
ulovirus system, which generates similar
recombinant protein levels, alphaviral vectors
possess the advantage of functioning well in
mammalian cells.
Alphaviral vector systems have been partic-
ularly useful for the heterologous expression of
receptors, including G protein-coupled recep-
tors such as the metabotropic glutamate recep-
tors mGluR2, 3, 4, and 8 (19,44,45), the human
neurokinin-1 receptor (43,46), and the α1b-
adrenergic receptor (47). Radioligand binding
on intact cells and isolated cell membranes
revealed extremely high expression levels,
with 3–10 million receptors per cell and 50–200
pmol recombinant receptor per mg total pro-
tein. An intact functional coupling of the over-
expressed receptors to G proteins in response
to agonists has been tested via measurements
of, e.g., GTPγS binding (44), intracellular Ca2+
mobilization (43), and inositol phosphate accu-
mulation (47).
In speciﬁc applications, the heterologous
expression of distinct proteins, possibly at
approximately equal ratios, within a given cell
is required. For example, it has been shown for
the GABAA receptor that α1 or β2 subunits,
when expressed alone, are retained in the
endoplasmic reticulum, whereas co-expression
of both subunits permits GABAA receptor
access to the plasma membrane (48). Separate
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genes can be introduced into the same cell by
co-infection with different viral vectors (47,48),
the use of internal ribosomal entry site (IRES)
sequences (67), and additional 26S subgenomic
RNA promoters (18).
Identiﬁcation of Infected Neurons 
Using GFP
The function of transduced neurons is gener-
ally compared to one of uninfected control
neurons (as well as to one of neurons infected
with a control virus expressing, e.g., GFP) to
determine the effect of the expressed trans-
gene. This comparison is done ideally in the
same population of cells, i.e., the same slice
culture or the same Petri dish. Electrophysio-
logical recordings, as well as other measure-
ments from infected cells, thus require the
identiﬁcation of (living) cells that have been
genetically modiﬁed. This is normally
achieved by using GFP as a reporter molecule.
Three GFP-based approaches have been
employed in combination with alphaviral vec-
tors. The most common method is the genera-
tion of GFP fusion proteins where the gene of
interest is fused to the GFP cDNA. This strat-
egy, however, may be problematic as the
attachment of the GFP domain can alter trans-
port, localization, and function of the overex-
pressed protein. A second approach is the use
of an internal ribosomal entry site (IRES)
sequence between the gene of interest and the
GFP cDNA, permitting separate expression of
both genes. Our experiments using IRES-
dependent GFP expression, however, revealed
relatively weak GFP ﬂuorescence and allowed
identiﬁcation of infected pyramidal cells in
organotypic hippocampal slices at only 3 d
post-infection. A third method is to drive GFP
expression separately under the control of an
additional subgenomic alphaviral 26S pro-
moter downstream of the gene of interest. This
procedure, in our hands, resulted in sufﬁ-
ciently high GFP ﬂuorescence levels to allow
for electrophysiological recordings from GFP-
positive primary neurons at 1 d post-infection.
The second and third approaches, of course,
can generally be used to express two or more
transgenes as separate proteins, which may be
required, e.g., for the expression of heteromeric
proteins such as ligand-gated ion channels.
Alphaviral Vector Development
As summarized in Table 1, wild-type
alphaviral vectors may be problematic because
of 1) cytotoxicity; 2) short-term expression due
to cytotoxicity and/or transient nature of the
viral RNA; 3) no choice of promoter; and 4) in
certain cases, extremely high expression levels.
The development of alternative SFV and SIN
vectors focuses on these negative properties by
introducing speciﬁc mutations in the nsP1–4
genes that control viral replication and expres-
sion. Tables 3 and 4 give an overview of the
modiﬁed alphaviral vectors and indicate their
transduction characteristics in cell lines and
neurons.
Non-Cytopathic Vectors
Spontaneous mutations discovered in the
nonstructural genes, particularly in nsP2 and
nsP4, have dramatic effects on the viral patho-
genicity. Mutations in nsP2 of SIN have pro-
duced viruses (49) and replicons (49–51) with
greatly reduced cytotoxicity in cell lines (see
Table 3). The majority of the mutants had a sin-
gle change at amino acid 726. For example, a
change at this site from Pro to Ser produced
replicons that had reduced levels of RNA repli-
cation, and therefore, also lower cytopatho-
genicity (49). The change from Pro to Leu led
to a further reduction in both RNA synthesis
and cytotoxicity (50). Replication-persistent
replicons with ongoing viral multiplication
were generated by random mutagenesis of nsP
genes in SIN and SFV vectors containing the
neomycin resistance gene; once again they had
either deletions or point mutations in nsP2
(51). All of these experiments were performed
in cell lines (see Table 3), with mitosis of
infected cells. In general, persistent infections
appeared to be correlated with a lack of inter-
feron production or the production of other
potential cytokines.
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With regard to neuronal infection (see Table
4), the introduction of known temperature-
sensitive mutations into nsP2 and nsP4
reduced the cytotoxicity of SFV vectors in pri-
mary hippocampal neurons (39). Further-
more, studies on replication-competent SFV
revealed a point mutation (Arg649Asp) in the
nuclear localization signal of nsP2 to confer
lower neurovirulence in mice (52,53). When
we combined a similar mutation in the nsP2
nuclear localization signal (Arg650Asp) with
an additional mutation in nsP2 (Ser259Pro),
we obtained a vector, SFV(PD), that was less
cytopathic and caused increased transgene
expression in mammalian cell lines, primary
hippocampal and cortical neurons, and
organotypic hippocampal slices (38,39) (K.
Lundstrom, A. Abenavoli, A. Malgaroli, and
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Table 3
Mutant SFV and SIN Replicons and Their Transduction Characteristics in Cell Lines Compared 
to the Conventional, Wild-Type Vectors SINrep5 (15) and SFV1 (13)
Vector Characteristics Refs.
SIN(nsP2A1E) Non-cytopathic in BHK cells, establishes (51)
persistent infectiona
SIN(nsP2P726S) Less cytopathic in BHK cells, noncytopathic (49)
in mouse and human cell lines, higher 
expression in BHK cells
SIN(nsP2P726L/T) Noncytopathic in all cell lines tested, establish (50,51,90)
persistent infections in BHK, Vero and CHO 
cellsa
SIN(nsP2P726SnsP4G153E), pCytTS Temperature-inducible, DNA-based expression (57)
system in BHK, CHO-K1, C2C12, COS-7, 
and HEK 293 cellsa
SFV(nsP2L10T), SF2A; SFV(nsP2∆D469), Noncytopathic in BHK cells, establish persistent (51)
SF1B; SFV(nsP2L713P), SF2C infection
SFV(nsP2S259P,R649D), SFV(PD) Less cytopathic in BHK, HEK 293, and (38,39)b
CHO-K1 cells, higher expression, reduced 
viral titers
SFV(nsP2S259P,R650D,L713P), SFV(PD713P) Noncytopathic in BHK cells, temperature- c
sensitive, expresses at 31°C but not at 37°,
higher expression, low viral titers
SFV(nsP2S259P,R649DnsP4G153E), Temperature-sensitive in BHK cells, expresses (39)
SFV(PDE153) at 31°C but little at 37°
SFV(nsP2S259P,R649DnsP4G324E), Temperature-sensitive in BHK cells, expresses (39)
SFV(PDE324) at 31°C but little at 37°
SFV(nsP2S259P,R649D,M780TnsP4G153E), Temperature-sensitive in BHK cells, expresses (39)
SFV(PDTE) at 31°C but not at 37°, achieving higher 
expression
SFV(A774nsP) Temperature-sensitive in BHK cells, 
transduces ~100-fold more cells at 31 vs 37°C d
SFV(26S-M5), SFV(26S-M1), Decreased transgene expression levels (1, 3, 
SFV(26S-M3) and 30% of wild-type, respectively) (58)
a This mutant has only been used as a nonpackaged replicon.
b Plus unpublished data by K. Lundstrom, A. Abenavoli, A. Malgaroli, and M.U. Ehrengruber.
c K. Lundstrom and M.U. Ehrengruber, unpublished data.
d M.U. Ehrengruber, M. Renggli, M.J.V. Vähä-Koskela, A.E. Hinkkanen, and K. Lundstrom, unpublished data.
M.U. Ehrengruber, unpublished data). Fur-
thermore, when a mutation in nsP2 known to
confer replication-persistence (Leu713Pro; ref.
51) was inserted into SFV(PD), the resulting
vector SFV(PD713P) was noncytopathic in
BHK cells and still infected neurons in hip-
pocampal slice cultures (K. Lundstrom, and
M.U. Ehrengruber, unpublished data).
Taken together, the less cytopathic SFV and
SIN mutants will permit the application of
alphaviral vectors under more physiological
conditions. In addition to general overexpres-
sion of recombinant proteins, the vectors can
also be used to study expression kinetics and
signal transduction events (54), suppress genes
by antisense and ribozyme approaches, and
perform gene therapy trials with prolonged
gene expression.
Vectors with Temperature-Dependent
Regulation
In present SFV and SIN vectors, transgene
expression relies on the endogenous 26S
subgenomic RNA promoter. The minimal 26S
subgenomic RNA promoter consists of 19
nucleotides upstream and 5 nucleotides down-
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Table 4
Transduction Characteristics of SFV Replicons in Hippocampal and Other Neurons
Vector Characteristics Refs.
Conventional SFVa Infects primary rat hippocampal neurons, (25,26)
cytotoxic after >8–24 hs
Targets pyramidal cells and interneurons in rat (27,28)
hippocampal slices, neurons tolerate infection for 2–5 d
In vivo, infects striatal neurons in rat brain (29)
SFV(nsP2S259P,R650D), SFV(PD) Less cytopathic in primary rat hippocampal (39)b
and cortical neurons, higher expression
Targets pyramidal cells and interneurons in rat (28)
hippocampal slices
SFV(nsP2S259P,R650D,L713P), Transduces pyramidal cells in rat c
SFV(PD713P) hippocampal slices
SFV(nsP2S259P,R649DnsP4G153E), Targets interneurons at 31°C, but both pyramidal (39)
SFV(PDE153) cells and interneurons at 37°C in rat 
hippocampal slices
SFV(nsP2S259P,R649DnsP4G324E), Temperature-sensitive in primary rat hippocampal (39)
SFV(PDE324) neurons, expresses at 31°C but little at 37°C
SFV(nsP2S259P,R649D,M780TnsP4G153E), Transduces both pyramidal cells and interneurons (39)
SFV(PDTE) of rat hippocampal slices at 31°C but not at 37°C
SFV(A774nsP) Transduces selectively glial cells at 37°C, and only d
neurons at 31°C in primary rat hippocampal cells
Transduces selectively glia and other non-neuronal d
cells at 37°C, but also neurons at 31°C in rat 
hippocampal slices
Note that SIN vectors also efﬁciently transduce hippocampal neurons in primary culture (30,31), in slices (27,32), and
in vivo (30).
a The conventional vectors SFV1 (13) and SFV2gen (19) are based upon the cDNA for SFV4 that is derived from the
wild-type, virulent L10 strain (5).
b Plus unpublished data by K. Lundstrom, A. Abenavoli, A. Malgaroli, and M.U. Ehrengruber.
c K. Lundstrom, and M.U. Ehrengruber, unpublished data.
d M.U. Ehrengruber, M. Renggli, M.J.V. Vähä-Koskela, A.E. Hinkkanen, and K. Lundstrom, unpublished data.
stream of the transcription start site for the
subgenomic RNA, but its activity is enhanced
when neighboring sequences are included (1).
The 26S subgenomic RNA promoter functions
in the cytoplasm of infected cells, as it is the
compartment where the transcription of
alphaviruses occurs (cf Fig. 1). In contrast, the
nucleus is the compartment where “non-
alphaviral” promoters are functional that can
be regulated and transcribe RNA from DNA.
Thus, other means to control SFV and SIN-
mediated transgene expression have to be
found. Temperature-dependence is one of the
few ways to regulate alphavirus vectors that
replicate and are transcribed in the cytoplasm.
Temperature-sensitive mutations have been
described for SIN in each of the nsP genes
(55,56), and those in nsP4 (14) have been intro-
duced into SIN expression vectors (57). Combi-
nation of the Pro726Ser change in nsP2 with a
temperature-sensitive mutation in nsP4 led to
the inducible expression of DNA-based vectors
in a variety of cell lines (57). Several of the
known temperature-sensitive point mutations
in nsP2 and nsP4 have also been introduced
into the SFV expression vector, causing tem-
perature-sensitive transgene expression in cell
lines, primary hippocampal neurons, and
organotypic hippocampal slices (see Tables 3
and 4) (39). A quadruple-mutant vector,
SFV(PDTE), with three point mutations in
nsP2 and one in nsP4, permitted GFP expres-
sion at 31°C but not at 37°C. Similarly,
SFV(PD713P) permitted transgene expression
at 31°C rather than 37°C (K. Lundstrom and
M.U. Ehrengruber, unpublished data). Interest-
ingly, the triple-mutant vector SFV(PDE153)
when used at 37°C transduced interneurons,
rather than pyramidal cells in rat hippocampal
slices, characterized by a ratio of approx 0.6
between GFP-positive pyramidal cells and
interneurons (the corresponding ratio is >10
for the wild-type SFV vector) (28). When
SFV(PDE153) was used at 31°C instead, a wild-
type phenotype was observed with a ratio of
approx 10 (39). A different study revealed
another SFV mutant, SFV(A774nsP) encoding
GFP downstream of the nsP genes from the
avirulent SFV strain A7(74), to transduce glial
cells, and not neurons, in cultured hippocam-
pal cells and slices at 37°C, whereas this was
reversed at 31°C (M.U. Ehrengruber, M. Reng-
gli, M.J.V. Vähä-Koskela, and K. Lundstrom,
unpublished data). These results show that
mutant alphaviral vectors are useful, at least in
hippocampal tissue, to target transgene expres-
sion to a subset of neurons or even glial cells
rather than principal neurons. At the non-per-
missive temperature, the host cellular environ-
ment presumably does not support alphaviral
replication.
Vectors with Decreased Expression Levels
For many applications, the elevated expres-
sion levels obtained with alphaviral vectors are
normally favorable or non-problematic. On the
other hand, they may be detrimental under
speciﬁc conditions—in particular when the
overexpressed protein has cytotoxic effects or
when more physiological levels of the
expressed protein are essential (the functional
expression of G protein-coupled receptors, e.g.,
may require a more physiological ratio of
receptors vs G proteins). To achieve lower
expression levels, several point mutations
were introduced into the 26S subgenomic RNA
promoter of SFV (see Table 3) (58). The result-
ing levels of reporter protein (β-galactosidase
and luciferase) expressed in BHK cells were
only 1, 3, and 30%, as compared to the quanti-
ties expressed from wild-type SFV vectors. The
down-regulated expression vectors will thus
permit examination of recombinant protein
function under conditions that are more simi-
lar to the in situ situation. The use of the GFP
reporter in combination with the more down-
regulated SFV vectors, however, will no longer
be practical (transduced cells will not be recog-
nized due to low GFP ﬂuorescence).
Comparison with Other Viral Vectors
Many viruses have been successfully
employed to transfer genes into neurons, and
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each viral vector has its advantages and disad-
vantages. As each vector system has normally
been established in a different laboratory and
tested under distinct conditions, it is some-
times difﬁcult for a newcomer to choose a viral
vector that is optimal for study. We have previ-
ously characterized wild-type SFV and
SFV(PD) vectors, recombinant adenovirus type
5, adeno-associated virus type 2 (AAV),
lentivirus, and measles virus by their expres-
sion of GFP in rat hippocampal slice cultures
(28). Figure 5 illustrates the results obtained
with a lentivirus expressing GFP under the
control of a cytomegalovirus (CMV) promoter.
Both SFV vectors transduced more neurons
(>90% of all GFP-positive cells) than AAV,
lentivirus, and measles virus (71, 69, and 62%,
respectively), while resting membrane poten-
tial and conductance, action potentials, ﬁring
accommodation, and H-current appeared nor-
mal in all infected CA1 pyramidal cells. No
infected neurons were identiﬁed with aden-
ovirus type 5 (28). This was an unexpected
ﬁnding because this virus is useful to trans-
duce primary rat hippocampal neurons (59),
although relatively high titers (approx 108
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Fig. 5. Transduction of rat hippocampal slices with a lentiviral vector. P6 rat hippocampal slices at 28 d in
culture were injected in the CA1 and CA3 pyramidal cell layer with two-fold diluted lentivirus expressing GFP
under a CMV promoter. Slices were incubated at 37°C and ﬁxed at 7 d post-infection. Fluorescence micrographs
of a whole slice (A), CA1 neurons (B), arrows, CA3 pyramidal cells (C), arrows, and glial cells in the CA1 region
(D), arrowheads. Abbreviations: DG, dentate gyrus; so, stratum oriens; sp, stratum pyramidale; sr, stratum radia-
tum. Bar: 260 µm (A), 65 µm (B–D).
plaque-forming units/mL) have to be applied
to overcome the predominant glial cell infec-
tion. AAV-mediated GFP expression was
restricted to neurons when the neuron-speciﬁc
PDGF promoter (for platelet-derived growth
factor β-chain) rather than the CMV promoter
was used. Whereas transgene expression medi-
ated by SFV was rapid but transient (as
described above), it increased more slowly but
remained stable with AAV and lentivirus, but
was fast with measles virus. As no replication-
impaired system is available for measles virus,
this vector propagated in the hippocampal
slices. It is noteworthy that spreading occurred
to pyramidal cells rather than non-neuronal
cells (60), which may facilitate the selective
transduction of most pyramidal cells within a
slice culture. In any case, SFV is useful for
short-term and AAV and lentivirus for long-
term transduction of hippocampal slices, while
measles virus may permit both short-and long-
term transduction.
A qualitative evaluation of the maximal
GFP expression levels obtained in hippocam-
pal slice cultures revealed the following order:
measles virus ≥ SFV ≈ lentivirus > AAV. Com-
pared to GFP-expressing lentivirus, the identi-
ﬁcation of neurons transduced with SFV and
SIN vectors encoding GFP was easier (cf Fig.
4A vs Fig. 5). We also estimated the transduc-
tion efﬁciencies in hippocampal slices by com-
paring the number of GFP positive cells vs the
number of applied virus particles. The follow-
ing order was found: wild-type SFV ≈
SFV(PD) > measles virus > lentivirus ≈ AAV-
PDGF-GFP > AAV-CMV-GFP (28). For SFV
and SFV(PD), nearly every virus particle
resulted in a GFP-positive cell. This high infec-
tion rate is due to the broad host range of the
virus, and the fact that entry of one virus par-
ticle sufﬁces to initiate viral replication in a
host cell (1,61). For SIN vectors in organotypic
hippocampal slices, similar results as with
SFV vectors are obtained (27). In addition to
the high infection rate, the easy generation of
high-titer virus stocks (36,37) that contain a
high ratio of infectious to physical particles
(61) makes SFV and SIN vectors favorable for
gene transfer into neurons. In several coun-
tries, SFV vectors packaged with pSFV-
Helper2 may be preferred as they are
classiﬁed as biosafety level 1.
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